About this trial
The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients diagnosed with or suspected to have a mitochondrial disorder
Adult carriers of known mitochondrial DNA mutations
Patients with laboratory analysis indicative of a mitochondrial disorder.
Medical information and tissue samples are also accepted from deceased individuals who fulfill the above criteria.
Disqualifiers
Patients not suspected of having a mitochondrial disorder
Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that affects mitochondrial function.
Trial population
Patients with known mitochondrial disorders. People at risk of carrying a mitochondrial DNA mutation Patients with abnormal mitochondrial function
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
There is no primary outcome measure for this study
This is a registry protocol and therefore there is no primary outcome measure for this study.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Columbia University
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator